Zeo ScientifiX (ZEOX) Total Debt Growth (3y) (2019 - 2024)
Zeo ScientifiX (ZEOX) Total Debt Growth (3y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.52% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -22.87% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.30% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.76% |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2024 | 15.08% |
| Apr 30, 2024 | 15.33% |
| Jan 31, 2024 | 13.71% |
| Oct 31, 2023 | 5.83% |
| Jul 31, 2023 | 29.86% |
| Apr 30, 2023 | 34.47% |
| Jan 31, 2023 | -0.76% |
| Oct 31, 2022 | 28.08% |
| Jul 31, 2022 | -31.86% |
| Apr 30, 2022 | -36.77% |
| Jan 31, 2022 | 9.30% |
| Oct 31, 2021 | 14.13% |
| Jul 31, 2019 | 56.84% |
| Apr 30, 2019 | 74.07% |
| Jan 31, 2019 | 70.12% |